Literature DB >> 24100258

Colchicine: New Insights to an Old Drug.

John Stack1, John Ryan, Geraldine McCarthy.   

Abstract

Colchicine is an ancient drug that is used for symptomatic relief in a wide range of inflammatory diseases including gout, Behçet syndrome, and familial Mediterranean fever. Recognition of its antiinflammatory properties and of its unpleasant gastrointestinal side effects date back thousands of years. Despite this, uncertainty remains concerning its mechanism of action and very few randomized controlled trials have been carried out to examine its safety and efficacy to date. Although it is an effective drug, its use is hindered by a very narrow therapeutic index. This review attempts to summarize recent developments concerning the use of colchicine in the treatment of gout with particular focus on its mechanism of action and toxicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24100258     DOI: 10.1097/01.mjt.0000433937.07244.e1

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  9 in total

Review 1.  Arterial and venous involvement in Behçet's syndrome: a narrative review.

Authors:  Neera Toledo-Samaniego; Crhistian Mario Oblitas; Eduardo Peñaloza-Martínez; Jorge Del-Toro-Cervera; Luis Antonio Alvarez-Sala-Walther; Pablo Demelo-Rodríguez; Francisco Galeano-Valle
Journal:  J Thromb Thrombolysis       Date:  2022-02-19       Impact factor: 2.300

2.  Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial.

Authors:  Peter Kelly; Christian Weimar; Robin Lemmens; Sean Murphy; Francisco Purroy; Anita Arsovska; Natan M Bornstein; Anna Czlonkowska; Urs Fischer; Ana Catarina Fonseca; John Forbes; Michael D Hill; Dalius Jatuzis; Janika Kõrv; Christina Kruuse; Robert Mikulik; Paul J Nederkoorn; Martin O'Donnell; Peter Sandercock; David Tanne; Georgios Tsivgoulis; Cathal Walsh; David Williams; Marialuisa Zedde; Christopher I Price
Journal:  Eur Stroke J       Date:  2021-06-18

Review 3.  Harnessing Plant Biodiversity for the Discovery of Novel Anticancer Drugs Targeting Microtubules.

Authors:  Songbo Xie; Jun Zhou
Journal:  Front Plant Sci       Date:  2017-05-04       Impact factor: 5.753

4.  [Cutaneous leukocytoclastic vasculitis: about 85 cases].

Authors:  Amina Aounallah; Aicha Arouss; Najet Ghariani; Wafa Saidi; Badreddine Sriha; Mohamed Denguezli; Colandane Belajouza; Rafia Nouira
Journal:  Pan Afr Med J       Date:  2017-03-14

Review 5.  The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke.

Authors:  Salvatore Rudilosso; Alejandro Rodríguez-Vázquez; Xabier Urra; Adrià Arboix
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

6.  Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure.

Authors:  Malinda S Tan; Ainhoa Gomez-Lumbreras; Lorenzo Villa-Zapata; Daniel C Malone
Journal:  Rheumatol Int       Date:  2022-09-14       Impact factor: 3.580

7.  High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen.

Authors:  Richard E Kast
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

8.  Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report.

Authors:  Maria Grazia Massaro; Maurizio Pompili; Luca L Sicignano; Fabrizio Pizzolante; Elena Verrecchia; Fabio M Vecchio; Donato Rigante; Raffaele Manna
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

9.  A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease.

Authors:  Stefan Grajek; Michał Michalak; Tomasz Urbanowicz; Anna Olasińska-Wiśniewska
Journal:  Front Cardiovasc Med       Date:  2021-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.